Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 131 JPY -1.21% Market Closed
Market Cap: 32.7B JPY

Daito Pharmaceutical Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Research & Development
-ÂĄ710.1B
CAGR 3-Years
-13%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Daiichi Sankyo Co Ltd
TSE:4568
Research & Development
-ÂĄ410.8B
CAGR 3-Years
-21%
CAGR 5-Years
-16%
CAGR 10-Years
-30%
Otsuka Holdings Co Ltd
TSE:4578
Research & Development
-ÂĄ314.2B
CAGR 3-Years
-11%
CAGR 5-Years
-8%
CAGR 10-Years
-2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Research & Development
-ÂĄ181.4B
CAGR 3-Years
-11%
CAGR 5-Years
-12%
CAGR 10-Years
-8%
Astellas Pharma Inc
TSE:4503
Research & Development
-ÂĄ329.3B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
-5%

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
32.6B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
3 121.87 JPY
Undervaluation 32%
Intrinsic Value
Price

See Also

Back to Top